stockrowDanaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.
- Revenue
- +8.28%
- EPS
- +36.7%
- Free cash flow
- +19.1%
- Total debt
- +44.9%
Quarter to September 2026, against a year earlier
Follow DHR
Alert me
Danaher Corporation (DHR) Operating cash flow
Danaher Corporation's operating cash flow for fiscal 2025 was $6.4B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $6.9B. Over the past ten years it has ranged from $3.5B (fiscal 2017) to $8.5B (fiscal 2022); the current reading is higher than 64% of that period. Operating cash flow has fallen for 3 consecutive fiscal years. Danaher Corporation ranks 2nd of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $6.4B | (4.07%) |
| FY2024 | $6.7B | (6.64%) |
| FY2023 | $7.2B | (15.91%) |
| FY2022 | $8.5B | 1.93% |
| FY2021 | $8.4B | 34.63% |
| FY2020 | $6.2B | 57.09% |
| FY2019 | $4.0B | (1.74%) |
| FY2018 | $4.0B | 15.65% |
| FY2017 | $3.5B | (1.25%) |
| FY2016 | $3.5B | (7.36%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $1.9B | 22.95% |
| Jun 2026 | $1.5B | 16.04% |
| Mar 2026 | $1.3B | (37.55%) |
| Dec 2025 | $2.1B | 27.38% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| TMO Thermo Fisher Scientific Inc. compare | $9.3B |
| DHR Danaher Corporation | $6.9B |
| IQV IQVIA Holdings Inc. compare | $2.7B |
| A Agilent Technologies, Inc. compare | $1.6B |
| IDXX IDEXX Laboratories, Inc. compare | $1.4B |
| ILMN Illumina, Inc. compare | $1.2B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| WAT Waters Corporation compare | $460.6M |
| NTRA Natera, Inc. compare | $212.8M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on DHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement